User login
Links we like
Medical news and content
ASH Press Releases
Bloomberg Health
Cardiology Today
digg.com Health
EurekAlert!
FDA-CDER
FDA-New Drug Approvals
FDA-Press Room
Google Health
Healthfinder.gov
Health News Review
HemOncToday
NHS Behind the Headlines
NYT Health
NYT Science
Ob.Gyn. News
Oncology Times
PipelineReview
PLoS ONE
PubMed
Johns Hopkins
Bloomberg Health
Cardiology Today
digg.com Health
EurekAlert!
FDA-CDER
FDA-New Drug Approvals
FDA-Press Room
Google Health
Healthfinder.gov
Health News Review
HemOncToday
NHS Behind the Headlines
NYT Health
NYT Science
Ob.Gyn. News
Oncology Times
PipelineReview
PLoS ONE
PubMed
Johns Hopkins
Blogs
Journals
Annals Internal Medicine
Blood
Cancer research
Haematologica (free!)
JAMA
JCO
JNCI
Journal Watch
Lancet
Lancet Oncology
Nature
NEJM
PLoS Medicine
Proceedings of the National Academy of Sciences
Science
Annals Internal Medicine
Blood
Cancer research
Haematologica (free!)
JAMA
JCO
JNCI
Journal Watch
Lancet
Lancet Oncology
Nature
NEJM
PLoS Medicine
Proceedings of the National Academy of Sciences
Science
Others
Check out the InteractMD.com podcast!
57224 visitors
57224 visitors
Dr. Michael Kirsch of MDWhistleblower now podcasting!
37941 visitors
37941 visitors
Similar
- Tykerb-Femara combo for breast cancer shows incremental benefit in early study
- 1cm HER-2 positive breast cancers have 23% recurrence rate
- Breast cancer epidemiology affects tumor biology
- 1cm HER-2 positive breast cancers have 23% recurrence rate
- Resveratrol prevents breast cancer malignant transformation in cell culture
Popular content
Today's:
All time:
Who's online
There are currently 0 users and 2 guests online.